These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34162664)

  • 21. Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanisms.
    Vergès B
    Diabetes Metab; 2020 Nov; 46(6):442-449. PubMed ID: 32998054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal and Cardiovascular Risk According to Tertiles of Urinary Albumin-to-Creatinine Ratio: The Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT).
    Marcovecchio ML; Chiesa ST; Armitage J; Daneman D; Donaghue KC; Jones TW; Mahmud FH; Marshall SM; Neil HAW; Dalton RN; Deanfield J; Dunger DB;
    Diabetes Care; 2018 Sep; 41(9):1963-1969. PubMed ID: 30026334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term population-based trends in the incidence of cardiovascular disease in individuals with type 1 diabetes from Finland: a retrospective, nationwide, cohort study.
    Harjutsalo V; Pongrac Barlovic D; Groop PH
    Lancet Diabetes Endocrinol; 2021 Sep; 9(9):575-585. PubMed ID: 34303414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal Frequency of Urinary Albumin Screening in Type 1 Diabetes.
    Perkins BA; Bebu I; de Boer IH; Molitch M; Zinman B; Bantle J; Lorenzi GM; Nathan DM; Lachin JM
    Diabetes Care; 2022 Dec; 45(12):2943-2949. PubMed ID: 36321737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study.
    Nin JW; Ferreira I; Schalkwijk CG; Jorsal A; Prins MH; Parving HH; Tarnow L; Rossing P; Stehouwer CD
    Diabetologia; 2012 Sep; 55(9):2489-93. PubMed ID: 22752054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.
    Nin JW; Jorsal A; Ferreira I; Schalkwijk CG; Prins MH; Parving HH; Tarnow L; Rossing P; Stehouwer CD
    Diabetes Care; 2011 Feb; 34(2):442-7. PubMed ID: 21270199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different lipid variables predict incident coronary artery disease in patients with type 1 diabetes with or without diabetic nephropathy: the FinnDiane study.
    Tolonen N; Forsblom C; Mäkinen VP; Harjutsalo V; Gordin D; Feodoroff M; Sandholm N; Thorn LM; Wadén J; Taskinen MR; Groop PH;
    Diabetes Care; 2014 Aug; 37(8):2374-82. PubMed ID: 24879842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excess Mortality in Patients With Type 1 Diabetes Without Albuminuria-Separating the Contribution of Early and Late Risks.
    Groop PH; Thomas M; Feodoroff M; Forsblom C; Harjutsalo V;
    Diabetes Care; 2018 Apr; 41(4):748-754. PubMed ID: 29378776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes.
    Thorn LM; Forsblom C; Wadén J; Saraheimo M; Tolonen N; Hietala K; Groop PH;
    Diabetes Care; 2009 May; 32(5):950-2. PubMed ID: 19196885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of Microvascular Complications and Effect of Concurrent Risk Factors in Type 1 Diabetes: A Multistate Model From an Observational Clinical Cohort Study.
    Bjerg L; Hulman A; Carstensen B; Charles M; Jørgensen ME; Witte DR
    Diabetes Care; 2018 Nov; 41(11):2297-2305. PubMed ID: 30131399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Pop-Busui R; Braffett BH; Zinman B; Martin C; White NH; Herman WH; Genuth S; Gubitosi-Klug R;
    Diabetes Care; 2017 Jan; 40(1):94-100. PubMed ID: 27803120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease and Mortality in Individuals With Type 2 Diabetes.
    Hanssen NMJ; Westerink J; Scheijen JLJM; van der Graaf Y; Stehouwer CDA; Schalkwijk CG;
    Diabetes Care; 2018 Aug; 41(8):1689-1695. PubMed ID: 29784769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.
    Theilade S; Hansen TW; Rossing P
    Am J Hypertens; 2014 Sep; 27(9):1152-9. PubMed ID: 24627444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.
    Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabet Med; 2012 Mar; 29(3):337-44. PubMed ID: 21988672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nut Consumption in Relation to Cardiovascular Disease Incidence and Mortality Among Patients With Diabetes Mellitus.
    Liu G; Guasch-Ferré M; Hu Y; Li Y; Hu FB; Rimm EB; Manson JE; Rexrode KM; Sun Q
    Circ Res; 2019 Mar; 124(6):920-929. PubMed ID: 30776978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Presence and Consequence of Nonalbuminuric Chronic Kidney Disease in Patients With Type 1 Diabetes.
    Thorn LM; Gordin D; Harjutsalo V; Hägg S; Masar R; Saraheimo M; Tolonen N; Wadén J; Groop PH; Forsblom CM;
    Diabetes Care; 2015 Nov; 38(11):2128-33. PubMed ID: 26310691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 30-Year Cardiovascular Disease in Type 1 Diabetes: Risk and Risk Factors Differ by Long-term Patterns of Glycemic Control.
    Miller RG; Orchard TJ; Costacou T
    Diabetes Care; 2022 Jan; 45(1):142-150. PubMed ID: 34782353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA).
    Pease A; Earnest A; Ranasinha S; Nanayakkara N; Liew D; Wischer N; Andrikopoulos S; Zoungas S
    Cardiovasc Diabetol; 2018 Jun; 17(1):77. PubMed ID: 29859534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors for Kidney Disease in Type 1 Diabetes.
    Perkins BA; Bebu I; de Boer IH; Molitch M; Tamborlane W; Lorenzi G; Herman W; White NH; Pop-Busui R; Paterson AD; Orchard T; Cowie C; Lachin JM;
    Diabetes Care; 2019 May; 42(5):883-890. PubMed ID: 30833370
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.